| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |